As per MRFR analysis, the Arbovirus Testing Market Size was estimated at 5.4 (USD Billion) in 2022. The Arbovirus Testing Market Industry is expected to grow from 5.87(USD Billion) in 2023 to 12.5 (USD Billion) by 2032. The Arbovirus Testing Market CAGR (growth rate) is expected to be around 8.75% during the forecast period (2024 - 2032).
The increasing incidence of arboviral diseases and improving diagnostic technologies are some of the key drivers in the market for arbovirus testing. Other opportunities are developing rapid and accurate point-of-care tests that can be used in remote and poorer regions of the world and exploring latest ideas such as nucleic acid testing and multiplex assays. Moreover, trends such as emergence of new arboviruses, more specific and sensitive tests, and increased application of molecular diagnostics are emerging. Such drivers, opportunities and trends can be used by manufacturers to explain how they are meeting the expectations of health care practitioners and patients and hence how they are enhancing the control and management of arboviral diseases.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Arboviral infections are a major public health concern, with an estimated 200 million cases occurring worldwide each year. The most common arboviral infections include dengue, chikungunya, Zika, and yellow fever. These infections can cause a wide range of symptoms, from mild fever and rash to severe illness and death. The rising prevalence of arboviral infections is a major driver of the growth of the Global Arbovirus Testing Market Industry. As the number of cases of arboviral infections increases, so too does the demand for testing to diagnose and monitor these infections.This is driving the growth of the Global Arbovirus Testing Market Industry, as manufacturers and suppliers of arbovirus testing products and services seek to meet the growing demand for these products and services.
Another major driver of the growth of the Global Arbovirus Testing Market Industry is the increasing awareness of arboviral infections. In recent years, there has been a growing awareness of the risks associated with arboviral infections, as well as the importance of their early diagnosis and treatment. This is due in part to the increasing number of arboviral infections cases, as well as the growing availability of information regarding these infections.As a result, as consumers become more aware of the risks associated with arboviral infections, they become more likely to go through arbovirus testing, which helps in the driving of the growth of the Global Arbovirus Testing Market Industry.
Technological advancements in arbovirus testing are also driving the growth of the Global Arbovirus Testing Market Industry. In recent years, there have been several technological advancements in arbovirus testing, which have made it easier, faster, and more accurate to diagnose arboviral infections. These advancements include the development of new diagnostic tests, as well as the improvement of existing tests. As these technological advancements continue, they are expected to further drive the growth of the Global Arbovirus Testing Market Industry.
The Global Arbovirus Testing Market is divided into two major types, laboratory-based tests and point-of-care tests. The laboratory-based tests refer to diagnostic tests for arboviral infections, which are performed in a laboratory, requiring specialized equipment and trained personnel. The point-of-care tests, on the other hand, include all test methods that can be carried out either at the bedside of the patient or in a clinic, which are cheaper and easier to use. While the superior accuracy and sensitivity of laboratory-based tests make them more popular, it is the point-of-care segment that is expected to grow more rapidly over the forecast period.In 2023, the laboratory-based tests segment is expected to generate 3.5 billion USD in revenue, which is higher than the 2.3 billion USD expected for the point-of-care segment. However, it will be the faster-growing segment over the forecast period, with a 2032 value of 7.2 billion USD for laboratory-based tests and 5.3 billion USD for point-of-care tests. The growth of the point-of-care tests segment is driven by several factors: the increase in arboviral infection rates, the growing demand for convenient and fast testing methods, and the popularity increase of point-of-care testing devices in general.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Based on pathogen detection, the global arbovirus testing market is categorized into two major segments: Vector-Based Testing and Human-Based Testing. The Vector-Based Testing segment held a substantial portion of the market revenue in 2023 and is likely to continue its dominance throughout the forecast period. This segment revolves around the analysis of mosquitoes or other vectors to detect arboviruses in them. Vector-based testing is largely fuelled by the rising incidence of vector-borne diseases and the need for effective surveillance and control measures.The Human-Based Testing segment is a type of testing that is employed to detect arboviruses in human samples such as blood or urine. This segment is poised to expand at an accelerated growth rate over the next years on account of the increasing knowledge and awareness about arboviral diseases and the availability of advanced diagnostic technologies.
The Global Arbovirus Testing Market is segmented by technology into serological testing, molecular testing, and immunofluorescence. Serological testing is expected to dominate the market in 2023, accounting for over 40% of the market share. This is due to its low cost and ease of use. Molecular testing is expected to grow at the fastest CAGR during the forecast period, owing to its high sensitivity and specificity. Immunofluorescence is expected to account for a small share of the market in 2023, but is expected to grow at a moderate CAGR during the forecast period.
The Global Arbovirus Testing Market is segmented based on application into diagnostic testing, surveillance, and research. Among these segments, diagnostic testing is expected to hold the largest share of the market in 2023, owing to the increasing prevalence of arboviral diseases worldwide. The demand for diagnostic testing kits is expected to grow significantly in the coming years, driven by factors such as the rising number of travelers visiting endemic areas, climate change, and the emergence of new arboviral strains. The surveillance segment is also expected to witness significant growth, as governments and public health organizations implement surveillance programs to track the spread of arboviral diseases and prevent outbreaks.The research segment is expected to grow at a moderate pace, driven by the need for continued research and development of new diagnostic tools and vaccines.
The Global Arbovirus Testing Market is segmented into North America, Europe, APAC, South America, and MEA. North America is expected to hold the largest market share in 2023, owing to the high prevalence of arboviral diseases, such as Zika virus and West Nile virus, in the region. Europe is expected to be the second-largest market, followed by APAC, South America, and MEA. The APAC region is expected to witness the highest growth rate during the forecast period, owing to the increasing awareness of arboviral diseases and the rising demand for diagnostic tests in the region.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Key players in the Arbovirus Testing Market are continuously developing innovative products to support the escalating demand for testing methods. Therefore, players in the market are investing in R activities to enhance the sensitivity, affordability, and specificity of the tests. Moreover, the Arbovirus Testing Market development is significantly influenced by strategic partnerships or collaborations among some of the key players as they aim to enhance their product range and establish a significant market presence. Thus, in the next few years, the competitive environment in the market is expected to be highly responsive to the influx of new technologies and entrants.Leading companies, such as Roche, offer a wide range of tests for various arboviruses. For example, the Elecsys Zika Virus IgM test and Elecsys Dengue Virus IgM test provided by this company have high sensitivity and specificity. The Elecsys tests allow rapid testing and early detection of Zika and dengue viruses with limited cost. Furthermore, Roche is continuously developing new testing products, and the company has recently developed several new tests, including the cobas Zika and cobas Chikungunya tests. Also, Roche is currently developing tests that will be useful for detection of yellow fever, another emerging arbovirus.Abbott Laboratories also offer a wide array of rapid tests, including the Panbio Dengue Early Rapid Test, which detects the dengue virus in a matter of minutes. Abbott is currently focusing on the development of molecular methods for rapid and effective detection of a wide range of arboviruses and the development of multiplex testing.
The Global Arbovirus Testing Market is projected to reach a valuation of USD 12.5 billion by 2032, expanding to a CAGR of 8.75% from 2024 to 2032. The market growth is attributed to the rising prevalence of arboviral diseases, increasing government initiatives for disease surveillance, and technological advancements in diagnostic methods. Asia-Pacific is expected to hold a significant market share due to the high incidence of arboviral diseases in the region. Key players in the market include Abbott Laboratories, bioMérieux, F. Hoffmann-La Roche, and Thermo Fisher Scientific. Recent developments include the approval of new diagnostic tests, such as the Arbovirus Multiplex RT-PCR Panel by the U.S. FDA, and the launch of rapid diagnostic tests for point-of-care settings.
| Report Attribute/Metric | Details |
| Market Size 2022 | 5.4(USD Billion) |
| Market Size 2023 | 5.87(USD Billion) |
| Market Size 2032 | 12.5(USD Billion) |
| Compound Annual Growth Rate (CAGR) | 8.75% (2024 - 2032) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2023 |
| Market Forecast Period | 2024 - 2032 |
| Historical Data | 2019 - 2023 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Thermo Fisher Scientific Inc., QIAGEN N.V., BioRad Laboratories, Danaher Corporation, DiaSorin S.p.A., Hologic Inc., Siemens Healthcare GmbH, Inverness Medical Innovations, Chembio Diagnostics, Ortho Clinical Diagnostics, Abbott Laboratories, Alere Inc., F. HoffmannLa Roche Ltd, Trinity Biotech Plc, Meridian Bioscience Inc. |
| Segments Covered | Test Type, Pathogen Detection, Technology, Application, Regional |
| Key Market Opportunities | Expanded testing capabilities Advancements in molecular diagnostics Growing prevalence of arboviral diseases Increased travel and globalization Technological advancements |
| Key Market Dynamics | Increasing disease prevalence Technological advancements Rising healthcare expenditure Growing demand for point of care tests Favorable government initiatives |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The global Arbovirus Testing Market is anticipated to be valued at approximately USD 5.87 billion in 2023.
The Global Arbovirus Testing Market is projected to expand at a CAGR of 8.75% from 2023 to 2032.
North America is expected to dominate the global Arbovirus Testing Market throughout the forecast period.
Rising prevalence of arboviral diseases, technological advancements, and increasing government initiatives are driving the market growth.
The diagnostics segment is expected to account for the largest market share due to the increasing demand for accurate and rapid testing methods.
Key competitors in the market include Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Ortho Clinical Diagnostics, and Siemens Healthineers.
The global Arbovirus Testing Market is projected to reach approximately USD 12.5 billion by 2032.
Asia Pacific is expected to witness the highest growth rate due to the increasing incidence of arboviral diseases and expanding healthcare infrastructure.
Challenges include the lack of awareness about arboviral diseases, limited access to diagnostic facilities in remote areas, and the need for skilled professionals.
Opportunities lie in the development of advanced testing technologies, strategic collaborations, and increasing government support for arbovirus surveillance and control programs.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
